Medical Condition News

RSS

Data from OncoSec Medical clinical studies to be presented at DNA Vaccines 2012 Conference

OncoSec Medical Inc., a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced it will be presenting at the DNA Vaccines 2012 Conference at the Loews Coronado Bay Resort in San Diego, California. OncoSec is a Silver Sponsor of the conference.

4 Dec 2012

EC grants CE mark to InSightec’s ExAblate Neuro ultrasound system

InSightec Ltd. announced that its transcranial focused ultrasound system, ExAblate Neuro, has been awarded the European CE mark for the treatment of neurological disorders in the brain including essential tremor, Parkinson's disease and neuropathic pain.

4 Dec 2012

VTT's PredictAD system promises to enable earlier diagnosis of Alzheimer's

A software tool called PredictAD developed by VTT Technical Research Centre of Finland promises to enable earlier diagnosis of the disease on the basis of patient measurements and large databases. Alzheimer's disease currently takes on average 20 months to diagnose in Europe.

4 Dec 2012

Linagliptin may reduce brain damage following stroke in type 2 diabetic patients

In a study in mice, scientists at Karolinska Institutet in Sweden have discovered a new potential therapy that may reduce brain damage following stroke in type 2 diabetic patients. The suggested drug is already approved for the treatment of type 2 diabetes. However, the scientists hope that this new results, presented in the scientific journal Diabetes, also opens up the possibility to decrease brain injury after stroke in other patient groups with a high stroke risk.

4 Dec 2012

psi-GSH prevents neurodegeneration associated with Alzheimer's in mouse model

Researchers at the University of Minnesota's Center for Drug Design have developed a synthetic compound that, in a mouse model, successfully prevents the neurodegeneration associated with Alzheimer's disease.

4 Dec 2012

InSightec receives European CE mark for ExAblate Neuro system

Elbit Imaging Ltd. announced today that on December 3, 2012, Elbit Medical Technologies Ltd., announced that InSightec Ltd. has been awarded the European CE mark for its transcranial focused ultrasound system, ExAblate Neuro, with respect to the treatment of neurological disorders in the brain, including essential tremor, Parkinson's disease and neuropathic pain.

4 Dec 2012

Healthy eating prevents second heart attack, stroke or death in people with CVD

A heart-healthy diet rich in fruits, vegetables and fish significantly reduces the chance of a second heart attack and stroke in people with cardiovascular disease, McMaster University researchers have found.

4 Dec 2012

Drug makers zero in on diabetes patients' social media connections

People living with diabetes have created a vibrant online community. Big drug companies are certainly taking notice - and some advocacy groups feel that the Food and Drug Administration should as well.

4 Dec 2012

Instituting and enforcing rules that limit aggressive acts should help reduce hockey injuries

Instituting and enforcing rules that limit aggressive acts like bodychecking in ice hockey should help reduce injuries for young players, including serious brain and spine injuries, according to a new study published in CMAJ (Canadian Medical Association Journal).

4 Dec 2012

Sorin Group’s Mitroflow valve receives Japanese PMDA approval

Sorin Group, a global medical company and a leader in the treatment of cardiovascular diseases, announced today that it received the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) approval for the Mitroflow Aortic Pericardial Heart Valve.

4 Dec 2012

Researchers derive dopaminergic neurons from bone marrow stem cells in monkeys

Parkinson's disease is a degenerative disorder of the central nervous system that is characterized by tremors, rigidity, slowness of movement, and difficulty walking. It is caused by loss of the neurons that produce the neurotransmitter dopamine (known as dopaminergic neurons). One of the primary goals in Parkinson's disease research is to develop a replacement for dopaminergic neurons.

4 Dec 2012

Many physicians misinformed about initial diagnosis and treatment of epilepsy

A survey of healthcare providers concerning the initial diagnosis and treatment of epilepsy has found significant misinformation held among physicians who see children who have seizures. Many physicians surveyed are misinformed about what constitutes intractable epilepsy, when to refer their pediatric patients for surgical evaluation, and what types of seizures may be amenable to surgical intervention.

4 Dec 2012

New screening tool to help reduce workplace accidents and illnesses

An international team of sleep researchers has developed the world's first screening tool to help reduce workplace accidents and illnesses, including cardiovascular disease and cancer, caused by shift work.

4 Dec 2012

New antibodies effective at preventing formation of toxic protein particles linked to Parkinson’s, AD

Antibodies developed by researchers at Rensselaer Polytechnic Institute are unusually effective at preventing the formation of toxic protein particles linked to Alzheimer's disease and Parkinson's disease, as well as Type 2 diabetes, according to a new study.

4 Dec 2012

Antidepressants in normal dosage may positively impact mood and seizure frequency

Epilepsy and depression are common co-morbidities. Concern for the potential of certain antidepressants to induce seizures has led to under-treating depression and anxiety disorders in epilepsy patients. Research presented today at the 66th American Epilepsy Society meeting suggests that antidepressants in normal dosage may have a positive impact on both mood and seizure frequency.

4 Dec 2012

Link between smoking, decreased bone density and osteoporosis risk in teenage girls

Teenage girls who smoke accumulate less bone during a critical growth period and carry a higher risk of developing osteoporosis later in life, according to new research in the Journal of Adolescent Health.

4 Dec 2012

Study describes 68 cases of chronic traumatic encephalopathy in athletes, military veterans

A study done by investigators at the Boston University Center for the Study of Traumatic Encephalopathy (CSTE) and the Veterans Affairs Boston Healthcare System, in collaboration with the Sports Legacy Institute (SLI), describes 68 cases of chronic traumatic encephalopathy (CTE) among deceased athletes and military veterans whose brain and spinal cords were donated to the VA CSTE Brain Bank.

4 Dec 2012

Studies explore F-18-FLT PET utility in providing prognostic information for patients with gliomas

In the management of gliomas-or tumors that originate in the brain-precise assessment of tumor grade and the proliferative activity of cells plays a major role in determining the most appropriate treatment and predicting overall survival.

4 Dec 2012

Pipeline embolization device shows promise in treating brain aneurysms

A new technology called the Pipeline embolization device (PED) shows encouraging results in patients with certain types of difficult-to-treat brain aneurysms, reports the December issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.

4 Dec 2012

Link between stress and brain activation in patients with seizure

A study reported here at the 66th American Epilepsy Society Annual Meeting has identified a significant difference in the brain response to stress in patients who believe stress is an important factor in their seizure control compared to patients who do not hold this belief.

4 Dec 2012

Medical Condition News

Data from OncoSec Medical clinical studies to be presented at DNA Vaccines 2012 Conference

EC grants CE mark to InSightec’s ExAblate Neuro ultrasound system

VTT's PredictAD system promises to enable earlier diagnosis of Alzheimer's

Linagliptin may reduce brain damage following stroke in type 2 diabetic patients

psi-GSH prevents neurodegeneration associated with Alzheimer's in mouse model

InSightec receives European CE mark for ExAblate Neuro system

Healthy eating prevents second heart attack, stroke or death in people with CVD

Drug makers zero in on diabetes patients' social media connections

Instituting and enforcing rules that limit aggressive acts should help reduce hockey injuries

Sorin Group’s Mitroflow valve receives Japanese PMDA approval

Researchers derive dopaminergic neurons from bone marrow stem cells in monkeys

Many physicians misinformed about initial diagnosis and treatment of epilepsy

New screening tool to help reduce workplace accidents and illnesses

New antibodies effective at preventing formation of toxic protein particles linked to Parkinson’s, AD

Antidepressants in normal dosage may positively impact mood and seizure frequency

Link between smoking, decreased bone density and osteoporosis risk in teenage girls

Study describes 68 cases of chronic traumatic encephalopathy in athletes, military veterans

Studies explore F-18-FLT PET utility in providing prognostic information for patients with gliomas

Pipeline embolization device shows promise in treating brain aneurysms

Link between stress and brain activation in patients with seizure

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Latest News